Michele Rhee

Michele Rhee is Vice President of Patient Experience at Savara Inc. She has two decades of experience leading patient advocacy and expanded access programs across biopharmaceutical and nonprofit industries. Michele was previously Vice President of Patient Affairs and Advocacy at X4 Pharmaceuticals, Head of Patient Affairs at Enzyvant, Global and R&D Patient Advocacy Lead at Takeda Oncology, Head of Patient Advocacy at bluebird bio, and Director of Strategic Initiatives and Program Initiatives at the National Brain Tumor Society. Michele received her MPH from Yale School of Public Health and MBA from Yale School of Management.